Biovac has supplied vaccines for the Expanded Programme on Immunisation (EPI) in South Africa since 2003. For the last 15 years we have played a pivotal role in supporting the South African Department of Health during introductions of new vaccines and during vaccination campaigns.
Currently, we supply over 25 million doses of vaccines annually to the South African provinces .
The following are the vaccines supplied and the diseases they prevent:
|Tuberculosis||Bacille Calmette-Guerin Vaccine – BCG|
|Poliomyelitis – Polio||Oral Polio Vaccine -OPV|
|Pneumonia||Pneumococcal Conjugate Vaccine|
|Diarrhoeal diseases caused by Rotavirus||Rotavirus Vaccine|
|Hepatitis B||Hepatitis B Vaccine|
|Cervical Cancer||Human Papillomavirus|
|Diptheria, Tetanus, Pertussis, Poliomyelitis, Haemophilus influenzae b infection and Hepatitis B||Hexavalent Vaccine|
|Diptheria and Tetanus||Diptheria and Tetanus Texoid Vaccine|
|Tetanus||Tetanus Toxoid Vaccine|
Beyond South Africa, Biovac supplies vaccines and other biologicals within the South African Development Community (SADC) region and continues to explore relationships to expand our reach.